OrbiMed: €4.6M-€92M checks, Seed to Growth
- Check size
- €4.6M – €92M
- Outreach
- Apply via form
Investment focus
Investment thesis
One of the world's largest healthcare-dedicated investment firms with ~$20B AUM, investing across the full spectrum from seed-stage biotech to large public companies.
How to Pitch OrbiMed
Apply through their form
Recent investments
Auto-extracted from press releases.
- 3 Oct 2026
- Series A · 17 Sept 2026
- Intellia Therapeuticsunverified5 Sept 2026
- Series A · 17 Jun 2026
Activity trend
Light data · +200%Last 90d
3
Prior 90d
1
Year ago
0
Portfolio highlights
BioAtla - conditionally active biologics
Nuvalent - precision oncology
ProKidney - regenerative cell therapy
Similar investors
Focus and check size from the firm's website. Website reachable as of Nov 2026.
Ready to reach OrbiMed?
Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.
Contact
orbimed.com
Reach OrbiMed through the links above. Pitchkit is not affiliated with the firm and does not forward pitches.